220 related articles for article (PubMed ID: 28341014)
1. Live pertussis vaccines: will they protect against carriage and spread of pertussis?
Locht C
Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S96-S102. PubMed ID: 28341014
[TBL] [Abstract][Full Text] [Related]
2. Pertussis: Where did we go wrong and what can we do about it?
Locht C
J Infect; 2016 Jul; 72 Suppl():S34-40. PubMed ID: 27161992
[TBL] [Abstract][Full Text] [Related]
3. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C
Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898
[TBL] [Abstract][Full Text] [Related]
4. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.
Thorstensson R; Trollfors B; Al-Tawil N; Jahnmatz M; Bergström J; Ljungman M; Törner A; Wehlin L; Van Broekhoven A; Bosman F; Debrie AS; Mielcarek N; Locht C
PLoS One; 2014; 9(1):e83449. PubMed ID: 24421886
[TBL] [Abstract][Full Text] [Related]
5. Will we have new pertussis vaccines?
Locht C
Vaccine; 2018 Aug; 36(36):5460-5469. PubMed ID: 29180031
[TBL] [Abstract][Full Text] [Related]
6. The Role of Mucosal Immunity in Pertussis.
Solans L; Locht C
Front Immunol; 2018; 9():3068. PubMed ID: 30692990
[TBL] [Abstract][Full Text] [Related]
7. Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice.
Feunou PF; Kammoun H; Debrie AS; Locht C
Vaccine; 2014 Jul; 32(34):4281-8. PubMed ID: 24950361
[TBL] [Abstract][Full Text] [Related]
8. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.
Feunou PF; Kammoun H; Debrie AS; Mielcarek N; Locht C
Vaccine; 2010 Oct; 28(43):7047-53. PubMed ID: 20708998
[TBL] [Abstract][Full Text] [Related]
9. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
[TBL] [Abstract][Full Text] [Related]
10. Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection.
Locht C; Papin JF; Lecher S; Debrie AS; Thalen M; Solovay K; Rubin K; Mielcarek N
J Infect Dis; 2017 Jul; 216(1):117-124. PubMed ID: 28535276
[TBL] [Abstract][Full Text] [Related]
11. New pertussis vaccination approaches: en route to protect newborns?
Locht C; Mielcarek N
FEMS Immunol Med Microbiol; 2012 Nov; 66(2):121-33. PubMed ID: 22574832
[TBL] [Abstract][Full Text] [Related]
12. New Pertussis Vaccines: A Need and a Challenge.
Hozbor D
Adv Exp Med Biol; 2019; 1183():115-126. PubMed ID: 31432399
[TBL] [Abstract][Full Text] [Related]
13. Early Protection against Pertussis Induced by Live Attenuated
Debrie AS; Mielcarek N; Lecher S; Roux X; Sirard JC; Locht C
J Immunol; 2019 Dec; 203(12):3293-3300. PubMed ID: 31732529
[TBL] [Abstract][Full Text] [Related]
14. Non-specific Effects of Live Attenuated Pertussis Vaccine Against Heterologous Infectious and Inflammatory Diseases.
Cauchi S; Locht C
Front Immunol; 2018; 9():2872. PubMed ID: 30581436
[No Abstract] [Full Text] [Related]
15. Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study.
Jahnmatz M; Richert L; Al-Tawil N; Storsaeter J; Colin C; Bauduin C; Thalen M; Solovay K; Rubin K; Mielcarek N; Thorstensson R; Locht C;
Lancet Infect Dis; 2020 Nov; 20(11):1290-1301. PubMed ID: 32687804
[TBL] [Abstract][Full Text] [Related]
16. Live attenuated vaccines against pertussis.
Locht C; Mielcarek N
Expert Rev Vaccines; 2014 Sep; 13(9):1147-58. PubMed ID: 25085735
[TBL] [Abstract][Full Text] [Related]
17. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial.
Jahnmatz M; Amu S; Ljungman M; Wehlin L; Chiodi F; Mielcarek N; Locht C; Thorstensson R
Vaccine; 2014 Jun; 32(27):3350-6. PubMed ID: 24793938
[TBL] [Abstract][Full Text] [Related]
18. What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.
Bolotin S; Harvill ET; Crowcroft NS
Pathog Dis; 2015 Nov; 73(8):ftv057. PubMed ID: 26253079
[TBL] [Abstract][Full Text] [Related]
19. Protective role of adenylate cyclase in the context of a live pertussis vaccine candidate.
Lim A; Ng JK; Locht C; Alonso S
Microbes Infect; 2014 Jan; 16(1):51-60. PubMed ID: 24140230
[TBL] [Abstract][Full Text] [Related]
20. [Pertussis vaccines: acellular versus whole cell. Perhaps a return to the past?].
Cofré J
Rev Chilena Infectol; 2015 Oct; 32(5):559-63. PubMed ID: 26633113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
